Epilepsy Therapeutics Market

Epilepsy Therapeutics Market (Product - First Generation Epilepsy Therapeutics, Second Generation Epilepsy Therapeutics, Third Generation Epilepsy Therapeutics; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • Rep Id : TMRGL2448
  • Published On : May 2019
  • No. of Pages : 166
  • Category : Pharmaceutical

1. Preface
       1.1. Market Definition and Scope
       1.2. Market Segmentation
       1.3. Key Research Objectives
       1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Epilepsy Therapeutics Market 

4. Market Overview
       4.1. Introduction
                4.1.1. Product Definition
                4.1.2. Industry Evolution / Developments
       4.2.  Overview
       4.3. Market Dynamics
                4.3.1. Drivers
                4.3.2. Restraints
                4.3.3. Opportunities
       4.4. Global Epilepsy Therapeutics Market  Analysis and Forecast, 2017–2027
                4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook
       5.1.Pipeline
       5.2.Epidemiology of Epilepsy
       5.3.Key Industry Events

6. Global Epilepsy Therapeutics Market  Analysis and Forecast, by Product 
       6.1. Introduction & Definition
       6.2. Key Findings / Developments
       6.3. Global Epilepsy Therapeutics Market Value Forecast, by Product, 2017–2027
                6.3.1. First Generation Epilepsy Therapeutics
                6.3.2. Second Generation Epilepsy Therapeutics
                6.3.3. Third Generation Epilepsy Therapeutics
       6.4. Global Epilepsy Therapeutics Market Attractiveness, by Product 

7. Global Epilepsy Therapeutics Market  Analysis and Forecast, by Distribution Channel 
       7.1. Introduction & Definition
       7.2. Key Findings / Developments
       7.3. Global Epilepsy Therapeutics Market Value Forecast, by Distribution Channel, 2017–2027
                7.3.1. Hospital Pharmacy 
                7.3.2. Retail Pharmacy 
                7.3.3. Online Pharmacy
       7.4. Global Epilepsy Therapeutics Market Attractiveness, by Distribution Channel 

8. Global Epilepsy Therapeutics Market  Analysis and Forecast, by Region
       8.1. Key Findings
       8.2. Global Epilepsy Therapeutics Market Value Forecast, by Region
                8.2.1. North America 
                8.2.2. Europe 
                8.2.3. Asia Pacific 
                8.2.4. Latin America 
                8.2.5. Middle East & Africa 
       8.3. Global Epilepsy Therapeutics Market Attractiveness, by Region

9. North America Epilepsy Therapeutics Market  Analysis and Forecast
       9.1. Introduction
                9.1.1. Key Findings
       9.2. North America Epilepsy Therapeutics Market Value Forecast, by Product, 2017–2027
                9.2.1. First Generation Epilepsy Therapeutics
                9.2.2. Second Generation Epilepsy Therapeutics
                9.2.3. Third Generation Epilepsy Therapeutics
       9.3. North America Epilepsy Therapeutics Market Value Forecast, by Distribution Channel, 2017–2027
                9.3.1. Hospital Pharmacy 
                9.3.2. Retail Pharmacy 
                9.3.3. Online Pharmacy
       9.4. North America Epilepsy Therapeutics Market Value Forecast, by Country, 2017–2027
                9.4.1. U.S.
                9.4.2. Canada
       9.5. North America Epilepsy Therapeutics Market Attractiveness Analysis 
                9.5.1. By Product 
                9.5.2. By Distribution Channel 
                9.5.3. By Country

10. Europe Epilepsy Therapeutics Market  Analysis and Forecast
       10.1. Introduction
                10.1.1. Key Findings
       10.2. Europe Epilepsy Therapeutics Market Value Forecast, by Product, 2017–2027
                10.2.1. First Generation Epilepsy Therapeutics
                10.2.2. Second Generation Epilepsy Therapeutics
                10.2.3. Third Generation Epilepsy Therapeutics
       10.3. Europe Epilepsy Therapeutics Market Value Forecast, by Distribution Channel, 2017–2027
                10.3.1. Hospital Pharmacy 
                10.3.2. Retail Pharmacy 
                10.3.3. Online Pharmacy
       10.4. Europe Epilepsy Therapeutics Market Value Forecast, by Country/Sub-region, 2017–2027
                10.4.1. Germany
                10.4.2. U.K.
                10.4.3. France
                10.4.4. Spain
                10.4.5. Italy
                10.4.6. Rest of Europe
       10.5. Europe Epilepsy Therapeutics Market Attractiveness Analysis 
                10.5.1. By Product 
                10.5.2. By Distribution Channel 
                10.5.3. By Country/Sub-region

11. Asia Pacific Epilepsy Therapeutics Market  Analysis and Forecast
       11.1.Introduction
                11.1.1. Key Findings
       11.2. Asia Pacific Epilepsy Therapeutics Market Value Forecast, by Product, 2017–2027
                11.2.1. First Generation Epilepsy Therapeutics
                11.2.2. Second Generation Epilepsy Therapeutics
                11.2.3. Third Generation Epilepsy Therapeutics
       11.3. Asia Pacific Epilepsy Therapeutics Market Value Forecast, by Distribution Channel, 2017–2027
                11.3.1. Hospital Pharmacy 
                11.3.2. Retail Pharmacy 
                11.3.3. Online Pharmacy
       11.4. Asia Pacific Epilepsy Therapeutics Market Value Forecast, by Country/Sub-region, 2017–2027
                11.4.1. China
                11.4.2. Japan
                11.4.3. India
                11.4.4. Australia & New Zealand
                11.4.5. Rest of Asia Pacific
       11.5. Asia Pacific Epilepsy Therapeutics Market Attractiveness Analysis 
                11.5.1. By Product 
                11.5.2. By Distribution Channel 
                11.5.3. By Country/Sub-region

12. Latin America Epilepsy Therapeutics Market  Analysis and Forecast
       12.1.Introduction
                12.1.1. Key Findings
       12.2. Latin America Epilepsy Therapeutics Market Value Forecast, by Product, 2017–2027
                12.2.1. First Generation Epilepsy Therapeutics
                12.2.2. Second Generation Epilepsy Therapeutics
                12.2.3. Third Generation Epilepsy Therapeutics
       12.3. Latin America Epilepsy Therapeutics Market Value Forecast, by Distribution Channel, 2017–2027
                12.3.1. Hospital Pharmacy 
                12.3.2. Retail Pharmacy 
                12.3.3. Online Pharmacy
       12.4. Latin America Epilepsy Therapeutics Market Value Forecast, by Country/Sub-region, 2017–2027
                12.4.1. Brazil
                12.4.2. Mexico
                12.4.3. Rest of Latin America
       12.5. Latin America Epilepsy Therapeutics Market Attractiveness Analysis 
                12.5.1. By Product 
                12.5.2. By Distribution Channel 
                12.5.3. By Country/Sub-region

13. Middle East & Africa Epilepsy Therapeutics Market  Analysis and Forecast
       13.1.Introduction
                13.1.1. Key Findings
       13.2. Middle East & Africa Epilepsy Therapeutics Market Value Forecast, by Product, 2017–2027
                13.2.1. First Generation Epilepsy Therapeutics
                13.2.2. Second Generation Epilepsy Therapeutics
                13.2.3. Third Generation Epilepsy Therapeutics
       13.3. Middle East & Africa Epilepsy Therapeutics Market Value Forecast, by Distribution Channel, 2017–2027
                13.3.1. Hospital Pharmacy 
                13.3.2. Retail Pharmacy 
                13.3.3. Online Pharmacy
       13.4. Middle East & Africa Epilepsy Therapeutics Market Value Forecast, by Country/Sub-region, 2017–2027
                13.4.1. GCC Countries
                13.4.2. South Africa
                13.4.3. Israel
                13.4.4. Rest of Middle East & Africa
       13.5. Middle East & Africa Epilepsy Therapeutics Market Attractiveness Analysis 
                13.5.1. By Product 
                13.5.2. By Distribution Channel 
                13.5.3. By Country/Sub-region

14. Competition Landscape
       14.1.Market Player – Competition Matrix (By Tier and Size of companies)
       14.2.Market Share Analysis By Company (2018)
       14.3. Company Profiles
                14.3.1. Pfizer, Inc.
                            14.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                            14.3.1.2. Company Financials
                            14.3.1.3.Growth Strategies
                            14.3.1.4. SWOT Analysis
                14.3.2. UCB S.A.
                            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                            14.3.2.2. Company Financials
                            14.3.2.3. Growth Strategies
                            14.3.2.4. SWOT Analysis
                14.3.3. Bausch Health Companies Inc.
                            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                            14.3.3.2. Company Financials
                            14.3.3.3. Growth Strategies
                            14.3.3.4. SWOT Analysis
                14.3.4. Novartis AG
                            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                            14.3.4.2. Company Financials
                            14.3.4.3. Growth Strategies
                            14.3.4.4. SWOT Analysis
                14.3.5. GlaxoSmithKline plc.
                            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                            14.3.5.2. Company Financials
                            14.3.5.3. Growth Strategies
                            14.3.5.4. SWOT Analysis
                14.3.6. Teva Pharmaceutical Industries Ltd.
                            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                            14.3.6.2. Company Financials
                            14.3.6.3. Growth Strategies
                            14.3.6.4. SWOT Analysis
                14.3.7. Sunovion Pharmaceuticals Inc.
                            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                            14.3.7.2. Company Financials
                            14.3.7.3. Growth Strategies
                            14.3.7.4. SWOT Analysis
                14.3.8. Eisai Co., Ltd.
                            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                            14.3.8.2. Company Financials
                            14.3.8.3. Growth Strategies
                            14.3.8.4. SWOT Analysis
                14.3.9. Upsher-Smith Laboratories, LLC.
                            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                            14.3.9.2. Company Financials
                            14.3.9.3. Growth Strategies
                            14.3.9.4. SWOT Analysis
                14.3.10. Amneal Pharmaceuticals LLC.
                            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                            14.3.10.2. Company Financials
                            14.3.10.3. Growth Strategies
                            14.3.10.4. SWOT Analysis

List of Tables
Table 01: Global Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 03: Global Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 04: North America Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 05: North America Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 06: North America Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel , 2017–2027
Table 07: Europe Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 08: Europe Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 09: Europe Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 10: Asia Pacific Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 11: Asia Pacific Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 12: Asia Pacific Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 13: Latin America Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 14: Latin America Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 15: Latin America Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 16: Middle East & Africa Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 17: Middle East & Africa Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 18: Middle East & Africa Epilepsy Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

List of Figure
Figure 01: Global Epilepsy Therapeutics Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027
Figure 02: Global Epilepsy Therapeutics Market Value (US$ Mn), by Product, 2018
Figure 03: Global Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%)  Projection, 2017–2027
Figure 04: Global Epilepsy Therapeutics Market Value Share (%), by Product, 2018 and 2027
Figure 05: Global Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by First Generation Epilepsy Therapeutics, 2017–2027
Figure 06: Global Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Second Generation Epilepsy Therapeutics, 2017–2027
Figure 07: Global Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Third Generation Epilepsy Therapeutics, 2017–2027
Figure 08: Global Epilepsy Therapeutics Market Attractiveness Analysis, by Product, 2019–2027
Figure 09: Global Epilepsy Therapeutics Market Value Share, by Distribution Channel, 2018 and 2027
Figure 10: Global Epilepsy Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
Figure 11: Global Epilepsy Therapeutics Market Value (US$ Mn) and Y-o-Y Growth, by Hospital Pharmacy, 2017–2027
Figure 12: Global Epilepsy Therapeutics Market Value (US$ Mn) and Y-o-Y Growth, by Retail Pharmacy , 2017–2027
Figure 13: Global Epilepsy Therapeutics Market Value (US$ Mn) and Y-o-Y Growth, by Online Pharmacy, 2017–2027
Figure 14: Global Epilepsy Therapeutics Market Value Share, by Region, 2018 and 2027
Figure 15: Global Epilepsy Therapeutics Market Attractiveness, by Region, 2019–2027
Figure 16: North America Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 17: North America Epilepsy Therapeutics Market Value Share (%), by Country, 2018 and 2027
Figure 18: North America Epilepsy Therapeutics Market Attractiveness, by Country, 2019–2027
Figure 19: North America Epilepsy Therapeutics Market Value Share, by Product, 2018 and 2027
Figure 20: North America Epilepsy Therapeutics Market Attractiveness, by Product, 2019–2027
Figure 21: North America Epilepsy Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 22: North America Epilepsy Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
Figure 23: Europe Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 24: Europe Epilepsy Therapeutics Market Value Share (%), by Country / Sub-region, 2018 and 2027
Figure 25: Europe Epilepsy Therapeutics Market Attractiveness, by Country / Sub-region, 2019–2027
Figure 26: Europe Epilepsy Therapeutics Market Value Share, by Product, 2018 and 2027
Figure 27: Europe Epilepsy Therapeutics Market Attractiveness, by Product, 2019–2027
Figure 28: Europe Epilepsy Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 29: Europe Epilepsy Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
Figure 30: Asia Pacific Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 31: Asia Pacific Epilepsy Therapeutics Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 32: Asia Pacific Epilepsy Therapeutics Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 33: Asia Pacific Epilepsy Therapeutics Market Value Share, by Product, 2018 and 2027
Figure 34: Asia Pacific Epilepsy Therapeutics Market Attractiveness, by Product, 2019–2027
Figure 35: Asia Pacific Epilepsy Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 36: Asia Pacific Epilepsy Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
Figure 37: Latin America Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 38: Latin America Epilepsy Therapeutics Market Value Share (%), by Country / Sub-region, 2018 and 2027
Figure 39: Europe Epilepsy Therapeutics Market Attractiveness, by Country / Sub-region, 2019–2027
Figure 40: Latin America Epilepsy Therapeutics Market Value Share, by Product, 2018 and 2027
Figure 41: Latin America Epilepsy Therapeutics Market Attractiveness, by Product, 2019–2027
Figure 42: Latin America Epilepsy Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 43: Latin America Epilepsy Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
Figure 44: Middle East & Africa Epilepsy Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017–2027
Figure 45: Middle East & Africa Epilepsy Therapeutics Market Value Share (%), by Country/Sub-region, 2018 and 2027
Figure 46: Middle East & Africa Epilepsy Therapeutics Market Attractiveness, by Country/Sub-region, 2019–2027
Figure 47: Middle East & Africa Epilepsy Therapeutics Market Value Share, by Product, 2018 and 2027
Figure 48: Middle East & Africa Epilepsy Therapeutics Market Attractiveness, by Product, 2019–2027
Figure 49: Middle East & Africa Epilepsy Therapeutics Market Value Share Analysis, by Distribution Channel, 2018 and 2027
Figure 50: Middle East & Africa Epilepsy Therapeutics Market Attractiveness, by Distribution Channel, 2019–2027
Figure 51: Pfizer, Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2016–2018
Figure 52: Pfizer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 53: Pfizer, Inc. Breakdown of Net Sales, by Geography 2018
Figure 54: Pfizer, Inc. Breakdown of Net Sales, by Business Segments (%), 2018
Figure 55: Bausch Health Companies Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 56: Bausch Health Companies Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 57: Bausch Health Companies Inc. Breakdown of Net Sales (%), by Region, 2017
Figure 58: Bausch Health Companies Inc. Breakdown of Revenues(%), by Product Category, 2017
Figure 59: UCB S.A. Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2018
Figure 60: UCB S.A. R&D Intensity and Sales & Marketing Intensity - Company Level, 2017–2018
Figure 61: UCB S.A. Breakdown of Net Sales, by Region, 2018
Figure 62: UCB S.A. Breakdown of Net Sales, by Therapeutic Area, 2018
Figure 63: Novartis AG Revenue (US$ Bn) and Y-o-Y Growth (%), 2016–2018
Figure 64: Novartis AG R&D Intensity and Sales & Marketing Intensity - Company Level, 2017–2018
Figure 65: Novartis AG Breakdown of Net Sales, by Region, 2018
Figure 66: Novartis AG Breakdown of Net Sales, by Business Segment, 2018
Figure 67: GlaxoSmithKline plc. Sales Revenue (US$ Mn) & Y-o-Y Growth (%), 2016–2018
Figure 68: GlaxoSmithKline plc. Breakdown of R&D Expenditure (US$ Mn), 2016-2018
Figure 69: GlaxoSmithKline plc. Breakdown of Net Sales, by Region, 2018
Figure 70: GlaxoSmithKline plc. Breakdown of Net Sales, by Business Segments, 2018
Figure 71: Teva Pharmaceutical Industries Ltd. Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 72: Teva Pharmaceutical Industries Ltd. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 73: Sumitomo Dainippon Pharma Co., Ltd Pharmaceuticals Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 74: Sumitomo Dainippon Pharma Co., Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 75: Sumitomo Dainippon Pharma Co., Ltd Breakdown of Pharmaceuticals Business Net Sales (%), by Region, 2017
Figure 76: Sumitomo Dainippon Pharma Co., Ltd Breakdown of Net Sales (%), by Product Segment, 2017
Figure 77: Eisai Co., Ltd., Revenue (US$ Mn), 2017–2018
Figure 78: Eisai Co., Ltd., R&D Expenses (US$ Mn), 2017–2018
Figure 79: Eisai Co., Ltd., Breakdown of Net Sales (%), by Region, 2018
Figure 80: Sawai Pharmaceutical, Co.,Ltd., Revenue (US$ Mn), 2017–2018
Figure 81: Sawai Pharmaceutical, Co.,Ltd., Ltd, R&D Expenses (US$ Mn), 2017–2018
Figure 82: Sawai Pharmaceutical, Co.,Ltd., Breakdown of Net Sales (%), by Region, 2018
Figure 83: Amneal Pharmaceuticals LLC., Revenue (US$ Mn) & Y-o-Y Growth (%), 2016–2018
Figure 84: Amneal Pharmaceuticals LLC., R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018

.